Pfizer: Mastering The Art Of The Deal With Metsera - Upgraded To Buy (NYSE:PFE)

Core Viewpoint - Pfizer Inc. has been in the news due to its agreement with the U.S. administration to provide direct-to-consumer discounted drugs, indicating a strategic move to enhance accessibility and affordability of its products [1]. Group 1 - Pfizer's recent deal with the U.S. administration aims to offer discounted drugs directly to consumers, which may improve its market position and public perception [1]. - The company is making a significant comeback, suggesting a potential recovery in its business performance and market confidence [1].